Want to track ATNM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Actinium Pharmaceuticals Inc. (ATNM) Statistics
Valuation metrics
Market Cap 31.69M
Enterprise value -3.44M
Trailing P/E (ttm) 2.81
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.9
Price/Book (mrq) 1.05
Enterprise Value/Revenue -0.1
Enterprise Value/EBITDA -0.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 110.2K
Average volume (90 days) 120.84K
Price summary
52-Week low 0.73
52-Week high 1.76
Beta -
50-Day moving average 0.87
200-Day moving average 1.1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 11 Aug 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.32%
Operating margin 0.27%
Operational effectiveness
Return on assets 0.28%
Return on equity 0.83%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.12
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.16
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 4.08%
Book value per share (mrq) 0.97
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
